Back to the main directory
EarningsReview / Equity
- A Christmas Wish: One Truck IPO by BNP Paribas Exane
- 2021 outlook: squeeze and the City by BNP Paribas Exane
- Investment Daily 15/12/2020 by BNP Paribas Exane
- INVEST SECURITIES - METRO : Fondations de la reprise compromises sur 2020/21 - NEUTRE, OC 7,5€ (vs 7,6€) by Invest Securities
- INDITEX: 3Q’20 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Positive signs, but uncertainty persists by BNP Paribas Exane
- Quick take on CarStory deal and added mgt. color by BNP Paribas Exane
- Axactor (Buy, TP: NOK13.00) - Cleaner and leaner by DnB Markets
- Edge computing event - what we learned by BNP Paribas Exane
- Zealand Pharma - CHI trial fails to meet primary endpoint by Danske Bank Equity Research
- INVEST SECURITIES - H&M : Potentiel insuffisant pour rester à la vente - NEUTRE vs VENTE, OC 162SEK (vs 157SEK) by Invest Securities
- INVEST SECURITIES - INDITEX : T3 de bonne facture pour un contexte difficile - ACHAT, OC 33,9€ (vs 33,3€) by Invest Securities
- Hiwin (2049 TT) by HSBC
- NetEnt (No_rec, TP: SEK) - by DnB Markets
- Novo Nordisk - Reaching for the stars by Danske Bank Equity Research
- The G word by BNP Paribas Exane
- INVEST SECURITIES - UBISOFT : Assassin's Creed devrait sauver l'exercice 2020-21 - VENTE, OC 70€ (vs 56€) by Invest Securities
- Investment Daily 17/12/2020 by BNP Paribas Exane
- MandA at invested companies continues by BNP Paribas Exane
- EIOPA''s Christmas Gift by BNP Paribas Exane
- Kahoot (Buy, TP: NOK98.00) - Earning from learning by DnB Markets
- Novo Nordisk (Buy, TP: DKK550.00) - Alzheimer’s opportunity by DnB Markets
- PhotoCure (Buy, TP: NOK135.00) - Fully focused on bladder cancer by DnB Markets
- Hexpol - Margin tailwind and an eventful 2021E by Danske Bank Equity Research
- Delivering well by BNP Paribas Exane
- In The Snow: The best and worst of 2020 by BNP Paribas Exane
- Virtual China Trip Feedback: still strong on the ground by BNP Paribas Exane
- INVEST SECURITIES - WORLDLINE : De bon augure pour la suite - ACHAT, OC 95€ by Invest Securities
- INDITEX: RDOS. 3T’20 (ANÁLISIS BANCO SABADELL) by Sabadell
- Airtac (1590 TT) by HSBC
- Revenio - Superior technology in a growing market by Danske Bank Equity Research
- Brrrr... by BNP Paribas Exane
- Aker Biomarine (Buy, TP: NOK120.00) - Circularity as a Service next by DnB Markets
- Conference Guide by BNP Paribas Exane
- Santander CIB: H&M: Early A/W ’20 Momentum Encouraging by Santander
- Santander CIB: Inditex: Early A/W ’20 Momentum Encouraging by Santander
- INVEST SECURITIES - BIOMERIEUX : Sanction exagérée, un marché trop exigeant - ACHAT, OC 146€ by Invest Securities
- Orphazyme - Three pivotal events pending – scenario report by Danske Bank Equity Research
- SSAB (Buy, TP: SEK38.00) - Party like its 2018 in Europe by DnB Markets
- The pushbacks by BNP Paribas Exane
- Sterling gains, euro savings by BNP Paribas Exane
- INVEST SECURITIES - CROSSJECT : Focus sur l'opérationnel - NEUTRE, OC 3,2€ (vs 2,7€) by Invest Securities
- INVEST SECURITIES - CONTINENTAL : Nouvelles ambitions, nouveau potentiel, OC relevé - ACHAT, OC 147€ (vs 122€) by Invest Securities
- Good entry point to play improved execution by BNP Paribas Exane
- Santa''s wish list by BNP Paribas Exane
- Hennes & Mauritz (Hold, TP: SEK180.00) - Wave after wave by DnB Markets
- Eagle Bulk Shipping (No_rec, TP: USD) - Recommendation and target price withdrawn by DnB Markets
- PhotoCure (Buy, TP: NOK135.00) - Fully focused on bladder cancer by DnB Markets
- EU targets big tech by BNP Paribas Exane
- The set-up we were looking for by BNP Paribas Exane